Witryna14 kwi 2024 · OGN stock opened at $23.98 on Friday. The firm has a market capitalization of $6.10 billion, a P/E ratio of 6.68, a price-to-earnings-growth ratio of 0.99 and a beta of 0.76. Organon & Co. has a ... Witryna5 lis 2024 · ORGANON PENSION TRUSTEES LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity. Cookies on Companies House services. We use some essential cookies to make our services work.
Organon: What’s Next for the New Merck & Co. Spin-off?
Witryna11 kwi 2024 · Organon & Co. specializes in the development, manufacture and marketing of pharmaceutical products for women's health, biosimilar medicines and drugs for the treatment of cardiovascular, respiratory and dermatological diseases. Net sales break down by family of products as follows: jesus the living christ
Organon Reports Results for the Fourth Quarter and Full Year …
WitrynaCharges for ORGANON PENSION TRUSTEES LIMITED (06406804) More for ORGANON PENSION TRUSTEES LIMITED (06406804) Filter charges Filter charges Outstanding / part satisfied 165 charges registered 148 outstanding, 17 satisfied, 0 part satisfied Charge code 0640 6804 0165. Satisfy charge 0640 6804 0165 ... Witryna12 kwi 2024 · Streubesitz. 99,9%. Mehr Finanzkennziffern. Unternehmensprofil. Organon & Co. (Organon) ist ein globales Gesundheitsunternehmen. Das Unternehmen ist in der Entwicklung und Bereitstellung von Gesundheitslösungen durch ein Portfolio von verschreibungspflichtigen Therapien im Bereich der Frauengesundheit, Biosimilars … Witryna11 kwi 2024 · 99,9%. More Financials. Company. Organon & Co. specializes in the development, manufacture and marketing of pharmaceutical products for women's health, biosimilar medicines and drugs for the treatment of cardiovascular, respiratory and dermatological diseases. Net sales break down by family of products as follows: - … inspired custom cabinets